American Healthcare REIT ... (AHR)
NYSE: AHR
· Real-Time Price · USD
40.22
-0.17 (-0.42%)
At close: Aug 15, 2025, 12:48 PM
American Healthcare REIT Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 |
Revenue | 2.15B | 2.11B | 2.07B | 2.01B | 1.95B | 1.91B | 1.86B | 1.83B | 1.78B | 1.7B | 1.62B | 1.53B | 1.11B | 730.56M | 359.64M |
Cost of Revenue | 1.29B | 1.68B | 1.65B | 1.61B | 1.57B | 1.54B | 1.5B | 1.48B | 1.44B | 1.36B | 1.28B | 1.21B | 867.75M | 571.7M | 284.54M |
Gross Profit | 856.55M | 429.05M | 416.77M | 402.15M | 384.03M | 370.66M | 356.83M | 348.1M | 341.67M | 334.3M | 335.97M | 322.28M | 240.13M | 158.86M | 75.11M |
Operating Income | 234M | 149.47M | 136.78M | 125.85M | 102.93M | 95.14M | 76.72M | 67.39M | 76.71M | 79.5M | 90.59M | 126.22M | 102.45M | 75.77M | 55.52M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -30.2M | -37.4M | -33.89M | -33.02M | -36.35M | -51.48M | -76.22M | -94.37M | -95.72M | -99.54M | -72.8M | -48.41M | -40.89M | -25.56M | -24.83M |
Net Income | -32.8M | -40.72M | -37.81M | -33.46M | -35.33M | -49.49M | -71.47M | -91.58M | -99.09M | -104.22M | -81.3M | -56.8M | -43.3M | -25.99M | -23.03M |
Selling & General & Admin | 91.92M | 102.04M | 100.8M | 100.09M | 100.93M | 102.29M | 104.98M | 107.22M | 105.78M | 104.94M | 103.1M | 96.06M | 71.59M | 46M | 19.59M |
Research & Development | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Expenses | 530.63M | 177.54M | 179.19M | 176.21M | 180.17M | 173.23M | 175.13M | 173.49M | 159.17M | 149.85M | 142.28M | 99.99M | 66.1M | 37.1M | n/a |
Operating Expenses | 622.54M | 279.58M | 279.99M | 276.3M | 281.1M | 275.52M | 280.11M | 280.71M | 264.95M | 254.8M | 245.38M | 196.05M | 137.69M | 83.09M | 19.59M |
Interest Expense | 61.01M | 114.24M | 127.73M | 138.61M | 150.22M | 160.62M | 163.19M | 156.77M | 142.29M | 121.64M | 105.96M | 71.19M | 43.67M | 23.32M | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 1.92B | 1.96B | 1.93B | 1.88B | 1.85B | 1.81B | 1.78B | 1.76B | 1.71B | 1.62B | 1.53B | 1.4B | 1.01B | 654.79M | 304.13M |
Income Tax Expense | 2.08M | 2.04M | 1.71M | 1.11M | 1.14M | 798K | 663K | 862K | 704K | 561K | 586K | 670K | 544K | 339K | 171K |
Shares Outstanding (Basic) | 160.5M | 156.92M | 153.7M | 133.73M | 130.53M | 104.3M | 66.05M | 66.05M | 66.03M | 66.03M | 66.15M | 66.08M | 66.08M | 66.21M | 65.6M |
Shares Outstanding (Diluted) | 161.14M | 156.92M | 153.7M | 133.73M | 130.69M | 104.3M | 66.05M | 66.05M | 66.03M | 66.03M | 66.15M | 66.08M | 66.08M | 66.21M | 65.6M |
EPS (Basic) | -0.22 | -0.27 | -0.26 | -0.47 | -0.53 | -0.73 | -1.08 | -1.38 | -1.49 | -1.57 | -1.22 | -0.85 | -0.65 | -0.39 | -0.35 |
EPS (Diluted) | -0.22 | -0.27 | -0.26 | -0.47 | -0.53 | -0.73 | -1.08 | -1.38 | -1.49 | -1.57 | -1.22 | -0.85 | -0.65 | -0.39 | -0.35 |
EBITDA | 292.18M | 294.84M | 315.48M | 322.25M | 339.83M | 335.96M | 324.26M | 304.19M | 274.71M | 239.26M | 233.76M | 255.29M | 185.73M | 134.72M | 63.65M |
EBIT | 88.35M | 76.84M | 93.84M | 105.6M | 113.88M | 109.14M | 86.97M | 62.4M | 46.56M | 22.1M | 33.16M | 48.35M | 28.34M | 23.34M | 739K |
Depreciation & Amortization | 203.83M | 218M | 221.64M | 216.65M | 225.95M | 226.82M | 237.3M | 241.79M | 228.15M | 217.16M | 200.6M | 206.94M | 157.38M | 111.39M | 62.91M |